Arrow Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.66M Sell
19,080
-942
-5% -$219K 0.47% 35
2025
Q4
$4.14M Sell
20,022
-107
-0.5% -$21.2K 0.41% 42
2025
Q3
$3.73M Sell
20,129
-81
-0.4% -$13.9K 0.38% 42
2025
Q2
$3.09M Sell
20,210
-398
-2% -$61.2K 0.33% 51
2025
Q1
$3.42M Sell
20,608
-9,657
-32% -$1.51M 0.38% 44
2024
Q4
$4.38M Sell
30,265
-160
-0.5% -$24.8K 0.42% 52
2024
Q3
$4.93M Sell
30,425
-1,241
-4% -$198K 0.46% 47
2024
Q2
$4.63M Sell
31,666
-559
-2% -$83.1K 0.45% 47
2024
Q1
$5.1M Sell
32,225
-1,946
-6% -$310K 0.51% 46
2023
Q4
$5.36M Sell
34,171
-2,212
-6% -$339K 0.56% 38
2023
Q3
$5.67M Sell
36,383
-8,097
-18% -$1.34M 0.66% 36
2023
Q2
$7.36M Sell
44,480
-1,416
-3% -$229K 0.89% 28
2023
Q1
$7.11M Sell
45,896
-1,804
-4% -$291K 0.93% 27
2022
Q4
$8.43M Sell
47,700
-232
-0.5% -$40.1K 1.14% 14
2022
Q3
$7.83M Sell
47,932
-108
-0.2% -$18.3K 1.14% 19
2022
Q2
$8.53M Sell
48,040
-789
-2% -$141K 1.16% 15
2022
Q1
$8.65M Sell
48,829
-627
-1% -$107K 1.04% 16
2021
Q4
$8.46M Sell
49,456
-851
-2% -$139K 1% 19
2021
Q3
$8.13M Sell
50,307
-377
-0.7% -$64.3K 1.05% 19
2021
Q2
$8.35M Sell
50,684
-794
-2% -$131K 1.06% 19
2021
Q1
$8.46M Sell
51,478
-517
-1% -$83.7K 1.12% 17
2020
Q4
$8.18M Sell
51,995
-620
-1% -$91.5K 1.59% 14
2020
Q3
$7.83M Sell
52,615
-3,818
-7% -$565K 1.66% 14
2020
Q2
$7.94M Sell
56,433
-585
-1% -$85.3K 1.73% 12
2020
Q1
$7.48M Sell
57,018
-28
-0% -$3.97K 1.77% 12
2019
Q4
$8.32M Sell
57,046
-2,060
-3% -$279K 1.62% 14
2019
Q3
$7.65M Sell
59,106
-487
-0.8% -$64.2K 1.59% 14
2019
Q2
$8.3M Buy
59,593
+379
+0.6% +$52.5K 1.78% 13
2019
Q1
$8.28M Sell
59,214
-672
-1% -$90K 1.92% 10
2018
Q4
$7.73M Buy
59,886
+122
+0.2% +$17K 1.98% 8
2018
Q3
$8.26M Buy
59,764
+87
+0.1% +$11.6K 1.73% 12
2018
Q2
$7.24M Sell
59,677
-4,166
-7% -$520K 1.63% 13
2018
Q1
$8.18M Buy
63,843
+4,380
+7% +$592K 1.9% 10
2017
Q4
$8.31M Sell
59,463
-892
-1% -$124K 1.92% 10
2017
Q3
$7.85M Sell
60,355
-542
-0.9% -$71.8K 1.86% 10
2017
Q2
$8.06M Sell
60,897
-379
-0.6% -$48.3K 1.93% 10
2017
Q1
$7.63M Sell
61,276
-641
-1% -$76.6K 1.86% 9
2016
Q4
$7.13M Sell
61,917
-1,204
-2% -$139K 1.77% 12
2016
Q3
$7.46M Sell
63,121
-1,146
-2% -$139K 1.9% 10
2016
Q2
$7.8M Sell
64,267
-921
-1% -$105K 2.03% 5
2016
Q1
$7.05M Buy
65,188
+227
+0.3% +$23.5K 1.87% 10
2015
Q4
$6.67M Sell
64,961
-405
-0.6% -$40.7K 1.78% 10
2015
Q3
$6.1M Sell
65,366
-413
-0.6% -$40K 1.73% 9
2015
Q2
$6.41M Buy
65,779
+811
+1% +$81.2K 1.74% 7
2015
Q1
$6.54M Sell
64,968
-1,342
-2% -$136K 1.76% 5
2014
Q4
$6.93M Sell
66,310
-447
-0.7% -$47.1K 1.89% 5
2014
Q3
$7.12M Buy
66,757
+404
+0.6% +$41.9K 1.97% 5
2014
Q2
$6.94M Sell
66,353
-115
-0.2% -$11.6K 1.88% 7
2014
Q1
$6.53M Sell
66,468
-1,328
-2% -$123K 1.85% 6
2013
Q4
$6.21M Buy
67,796
+20
+0% +$1.84K 1.78% 7
2013
Q3
$5.88M Sell
67,776
-1,369
-2% -$123K 1.8% 7
2013
Q2
$5.94M Buy
+69,145
New +$5.87M 1.9% 7

Other funds holding JNJ

Arrow Financial's JNJ Position: Q1 2026 in Review

Arrow Financial reduced its Johnson & Johnson (JNJ) stake by 4.7% in Q1 2026, selling an estimated $219K and leaving 19,080 shares worth $4.66M. The position accounts for 0.47% of the portfolio, ranked #35.

Arrow Financial first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.65M in Q1 2022. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Arrow Financial held 19,080 shares of Johnson & Johnson worth $4.66M as of Q1 2026.
  • Arrow Financial sold 942 Johnson & Johnson shares in Q1 2026, an estimated $219K.
  • Johnson & Johnson made up 0.47% of Arrow Financial's portfolio in Q1 2026, its #35 holding.
  • Arrow Financial first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Arrow Financial's Johnson & Johnson position peaked at $8.65M in Q1 2022.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Arrow Financial's 13F filing for Q1 2026, filed 11 May 2026.